Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic

por McGoran, John, Wilson, Alan, McErlain, Shannan, Kennedy, Noreen, Masterson, Caroline, Collins, Caroline, Morrison, Graham
Publicado 2021